
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.520 | 0.520 | 0.000 |
Shares | 98.850 | 98.850 | 0.000 |
Other | 0.630 | 0.630 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 15.751 | 14.958 |
Price to Book | 2.260 | 2.080 |
Price to Sales | 1.781 | 1.477 |
Price to Cash Flow | 10.572 | 9.340 |
Dividend Yield | 3.399 | 3.335 |
5 Years Earnings Growth | 8.581 | 8.986 |
Name | Net % | Category Average |
---|---|---|
Financial Services | 22.840 | 20.530 |
Industrials | 19.990 | 17.580 |
Healthcare | 12.780 | 13.335 |
Consumer Defensive | 9.950 | 10.686 |
Technology | 7.580 | 9.260 |
Consumer Cyclical | 6.600 | 9.019 |
Basic Materials | 5.780 | 6.153 |
Communication Services | 4.580 | 5.662 |
Energy | 4.580 | 4.226 |
Utilities | 4.470 | 4.704 |
Real Estate | 0.850 | 1.658 |
Number of long holdings: 240
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
SAP | DE0007164600 | 2.71 | 227.975 | -2.53% | |
ASML Holding | NL0010273215 | 2.31 | 616.80 | -3.03% | |
Novartis | CH0012005267 | 2.10 | 101.56 | +0.02% | |
Roche Holding Participation | CH0012032048 | 1.88 | 262.70 | +0.96% | |
AstraZeneca | GB0009895292 | 1.80 | 11,966.0 | +0.98% | |
Nestle | CH0038863350 | 1.78 | 75.33 | -0.21% | |
Shell | GB00BP6MXD84 | 1.68 | 31.59 | +0.08% | |
HSBC | GB0005405286 | 1.56 | 951.60 | -0.21% | |
Siemens AG | DE0007236101 | 1.52 | 229.78 | -3.94% | |
Novo Nordisk B | DK0062498333 | 1.46 | 358.5 | -1.82% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LU0058496679 | 2.6B | -3.15 | 10.86 | 9.67 | ||
LU0553726919 | 515.38M | 7.86 | -1.59 | 0.22 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review